(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 4.14% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.2%.
Neogen's revenue in 2023 is $630,719,000.On average, 2 Wall Street analysts forecast NEOG's revenue for 2023 to be $152,010,499,520, with the lowest NEOG revenue forecast at $121,111,244,765, and the highest NEOG revenue forecast at $182,909,754,275. On average, 2 Wall Street analysts forecast NEOG's revenue for 2024 to be $173,042,311,256, with the lowest NEOG revenue forecast at $129,584,492,659, and the highest NEOG revenue forecast at $216,500,129,853.
In 2025, NEOG is forecast to generate $137,944,259,554 in revenue, with the lowest revenue forecast at $137,944,259,554 and the highest revenue forecast at $137,944,259,554.